HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential prognostic importance of QRS duration in heart failure and acute myocardial infarction associated with left ventricular dysfunction.

AbstractBACKGROUND/AIMS:
Studies of the prognostic importance of QRS duration in patients with heart failure (HF) have shown conflicting results and few studies have estimated the importance after myocardial infarction (MI).
METHODS:
The Danish Investigations and Arrhythmia ON Dofetilide (DIAMOND) study randomised 3028 patients to dofetilide (class III antiarrhythmic) or placebo. The study consisted of two almost identical trials conducted simultaneously. One trial included 1518 patients with chronic HF and the other trial 1510 patients with a recent MI. All patients had left ventricular dysfunction. Dofetilide did not influence mortality in either trial. QRS duration was systematically measured at randomisation and was available in 2972 patients.
RESULTS:
Over a 10 year observation period 1037 (70%) patients in the MI study and 1324 (87%) in the HF study died. In the MI study, risk of death increased 6% for each 10 ms increase in QRS duration (HR=1.06/10 ms increase in QRS (CI=1.04-1.09), p<0.0001) whereas QRS duration had no influence in the HF study after multivariable adjustment. The difference between HF and MI was significant (p<0.0004 for interaction).
CONCLUSION:
QRS duration predicts death in patients with left ventricular dysfunction who have suffered MI. In patients with HF QRS duration is not predictive of mortality.
AuthorsEmil Loldrup Fosbøl, Marie Seibaek, Bente Brendorp, Daniél Vega Møller, Mads Ersbøll, Christian Torp-Pedersen, Lars Køber, Danish Investigations and Arrhythmia ON Dofetilide (DIAMOND) study group
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 9 Issue 8 Pg. 814-9 (Aug 2007) ISSN: 1388-9842 [Print] England
PMID17572147 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Topics
  • Aged
  • Aged, 80 and over
  • Female
  • Heart Conduction System (physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (mortality, physiopathology)
  • Prognosis
  • Proportional Hazards Models
  • Ventricular Dysfunction, Left (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: